Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study. [electronic resource] by
- Goy, Andre
- Sinha, Rajni
- Williams, Michael E
- Kalayoglu Besisik, Sevgi
- Drach, Johannes
- Ramchandren, Radhakrishnan
- Zhang, Lei
- Cicero, Sherri
- Fu, Tommy
- Witzig, Thomas E
Producer: 20131125
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31
Availability: No items available.
|
|
|
11.
|
Cancer Site and Adverse Events Induced by Immune Checkpoint Inhibitors: A Retrospective Analysis of Real-life Experience at a Single Institution. [electronic resource] by
- Sukari, Ammar
- Nagasaka, Misako
- Alhasan, Roba
- Patel, Dhaval
- Wozniak, Antoinette
- Ramchandren, Radhakrishnan
- Vaishampayan, Ulka
- Weise, Amy
- Flaherty, Lawrence
- Jang, Hyejeong
- Kim, Seongho
- Gadgeel, Shirish
Producer: 20190220
In:
Anticancer research vol. 39
Availability: No items available.
|
|
|
12.
|
Brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive haematologic malignancies and hepatic or renal impairment. [electronic resource] by
- Zhao, Baiteng
- Chen, Robert
- O'Connor, Owen A
- Gopal, Ajay K
- Ramchandren, Radhakrishnan
- Goy, Andre
- Matous, Jeffrey V
- Fasanmade, Adedigbo A
- Manley, Thomas J
- Han, Tae H
Producer: 20171113
In:
British journal of clinical pharmacology vol. 82
Availability: No items available.
|
|
|
13.
|
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B-cell lymphoma. [electronic resource] by
- Herrera, Alex F
- Goy, Andre
- Mehta, Amitkumar
- Ramchandren, Radhakrishnan
- Pagel, John M
- Svoboda, Jakub
- Guan, Shanhong
- Hill, John S
- Kwei, Kevin
- Liu, Emily A
- Phillips, Tycel
Producer: 20200511
In:
American journal of hematology vol. 95
Availability: No items available.
|
|
|
14.
|
Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis. [electronic resource] by
- Xu, Mina L
- Gabali, Ali
- Hsi, Eric D
- Fedoriw, Yuri
- Vij, Kiran
- Salama, Mohamed E
- Ramchandren, Radhakrishnan
- O'Malley, Dennis
- Wick, Mark R
- Battistella, Maxime
- Gru, Alejandro A
Producer: 20200513
In:
The American journal of surgical pathology vol. 44
Availability: No items available.
|
|
|
15.
|
CYP3A-mediated drug-drug interaction potential and excretion of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive hematologic malignancies. [electronic resource] by
- Han, Tae H
- Gopal, Ajay K
- Ramchandren, Radhakrishnan
- Goy, Andre
- Chen, Robert
- Matous, Jeffrey V
- Cooper, Maureen
- Grove, Laurie E
- Alley, Stephen C
- Lynch, Carmel M
- O'Connor, Owen A
Producer: 20140320
In:
Journal of clinical pharmacology vol. 53
Availability: No items available.
|
|
|
16.
|
Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non-germinal center B-cell-like DLBCL. [electronic resource] by
- Goy, Andre
- Ramchandren, Radhakrishnan
- Ghosh, Nilanjan
- Munoz, Javier
- Morgan, David S
- Dang, Nam H
- Knapp, Mark
- Delioukina, Maria
- Kingsley, Edwin
- Ping, Jerry
- Beaupre, Darrin M
- Neuenburg, Jutta K
- Ruan, Jia
Producer: 20200130
In:
Blood vol. 134
Availability: No items available.
|
|
|
17.
|
Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. [electronic resource] by
- Illidge, Tim
- Bouabdallah, Reda
- Chen, Robert
- Gopal, Ajay K
- Moskowitz, Craig H
- Ramchandren, Radhakrishnan
- Shustov, Andrei R
- Tilly, Herve
- Trippett, Tanya M
- Gibb, Adam
- Grove, Laurie E
- Advani, Ranjana
Producer: 20160314
In:
Leukemia & lymphoma vol. 56
Availability: No items available.
|
|
|
18.
|
Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial. [electronic resource] by
- Goy, Andre
- Kalayoglu Besisik, Sevgi
- Drach, Johannes
- Ramchandren, Radhakrishnan
- Robertson, Michael J
- Avivi, Irit
- Rowe, Jacob M
- Herbrecht, Raoul
- Van Hoof, Achiel
- Zhang, Lei
- Cicero, Sherri
- Fu, Tommy
- Witzig, Thomas
Producer: 20151016
In:
British journal of haematology vol. 170
Availability: No items available.
|
|
|
19.
|
Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation. [electronic resource] by
- Gopal, Ajay K
- Ramchandren, Radhakrishnan
- O'Connor, Owen A
- Berryman, Robert B
- Advani, Ranjana H
- Chen, Robert
- Smith, Scott E
- Cooper, Maureen
- Rothe, Achim
- Matous, Jeffrey V
- Grove, Laurie E
- Zain, Jasmine
Producer: 20121002
In:
Blood vol. 120
Availability: No items available.
|
|
|
20.
|
Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma. [electronic resource] by
- Witzig, Thomas E
- Luigi Zinzani, Pier
- Habermann, Thomas M
- Tuscano, Joseph M
- Drach, Johannes
- Ramchandren, Radhakrishnan
- Kalayoglu Besisik, Sevgi
- Takeshita, Kenichi
- Casadebaig Bravo, Marie-Laure
- Zhang, Lei
- Fu, Tommy
- Goy, Andre
Producer: 20170925
In:
American journal of hematology vol. 92
Availability: No items available.
|